Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Aug 14, 2017; 23(30): 5602-5609
Published online Aug 14, 2017. doi: 10.3748/wjg.v23.i30.5602
Table 1 Comparison of serological indicators between the malignant and benign tumor groups
AFP (ng/mL)AFU (U/L)ALT (U/L)AST (U/L)GGT (U/L)ALP (U/L)
Malignant tumor group18.02 ± 5.0129.74 ± 14.2239.01 ± 3.6046.92 ± 12.1162.40 ± 27.30139.40 ± 85.90
Benign tumor group15.96 ± 4.3325.61 ± 13.1137.90 ± 4.3344.40 ± 11.6054.90 ± 22.30117.99 ± 57.30
t-value2.0811.4461.7051.4091.4091.328
P value0.040.1510.090.1620.1620.187
Table 2 Comparison of contrast-enhanced ultrasound parameters in the malignant and benign tumor groups
Start time (s)Initial strength (dB)Peak time (s)Peak intensity (dB)120s Echo intensity (dB)Peak acceleration time (s)Intensity increment (dB)Enhancement rate (dB/s)Extinction rate (dB/s)
Malignant tumor group11.98 ± 2.958.35 ± 6.0330.22 ± 9.6539.27 ± 6.3227.33 ± 17.8617.94 ± 4.6430.99 ± 6.672.24 ± 0.210.08 ± 0.07
Benign tumor group13.01 ± 3.926.57 ± 5.6633.33 ± 11.9637.77 ± 7.3032.01 ± 11.9620.10 ± 10.3231.22 ± 7.122.01 ± 0.310.06 ± 0.06
t-value-1.5321.463-1.4561.101-1.396-1.533-0.1642.5891.449
P value0.1280.1460.1480.2730.1660.1280.8700.0110.150